Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.2319
https://www.valueinhealthjournal.com/article/S1098-3015(15)04395-8/fulltext
Title :
Cost-Utility Analysis of Certolizumab Pegol for the Treatment of Active Psoriatic Arthritis in GREECE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04395-8&doi=10.1016/j.jval.2015.09.2319
First page :
A646
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1725